Impact of the Implementation of a Clinical Pharmacy Bundle on Intensive Care Unit Patient Outcomes and Cost Expenditures

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02924844

Enrollment

2787

Registered

2016-10-05

Start date

2013-01-01

Completion date

2015-06-01

Last updated

2026-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intensive Care

Brief summary

The aim of this before-after study was to assess the impact of a clinical pharmacy bundle of care activities on patient outcomes (length of hospital stay as a primary endpoint) and cost expenditure in two French ICUs.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Intensive Care Unit patients on weekdays

Design outcomes

Primary

Measure	Time frame
Length of hospital stay	expected average of 20 days

Secondary

Measure	Time frame
Intensive Care Unit length of stay	Expected maximum of 10 days
Mechanical ventilation duration	Expected maximum of 10 days
Intensive care unit mortality rate	Expected maximum of 10 days
Hospital mortality rate	End of hospital stay (expected average of 20 days)
Patient cost expenditure	End of hospital stay (expected average of 20 days)

Countries

France

Outcome results